Stargardt Disease
Stargardt disease, also known as Stargardt macular dystrophy or juvenile macular degeneration, is a genetic eye disorder that causes progressive vision loss. It is named after German ophthalmologist Karl Stargardt who first described the condition in 1901. The disease primarily affects the macula, the part of the retina responsible for sharp central vision. In individuals with Stargardt disease, the cells in the macula gradually break down, leading to a loss of central vision. Symptoms typically begin in childhood or adolescence and worsen over time, although the rate of progression can vary widely between affected individuals. Stargardt disease is caused by mutations in the ABCA4 gene, which provide instructions for making a protein that helps remove toxic waste products from cells in the retina. When these mutations occur, the protein becomes less effective, allowing harmful waste products to accumulate and damage cells in the retina. Symptoms of Stargardt disease include blurred or distorted central vision, difficulty seeing in low light or at night, and a loss of color vision. There is currently no cure for Stargardt disease, but treatment options may include low vision aids, such as magnifying glasses or telescopes, and genetic counseling. In conclusion, Stargardt disease is a genetic eye disorder that causes progressive vision loss. It primarily affects the macula, leading to a loss of central vision over time. The disease is caused by mutations in the ABCA4 gene and currently has no cure. Individuals with Stargardt disease can benefit from low vision aids and specialized care from an ophthalmologist.
← Journal of Ophthalmic Science